ArticleThe American journal of the medical sciences2023

Anticardiolipin and anti-beta-2 glycoprotein I antibodies in patients with moderate or severe COVID-19.

Gisela Garcia-Arellano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.